Suciu, Stefan
European Organisation for Research and Treatment of Cancer
5 papers on CoChatORCID 0000-0003-3281-8256
Most cited papers
- Verified
Adjuvant pembrolizumab versus placebo in resected stage III melanoma
Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., et al. (2018) · New England Journal of Medicine
Cutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers
Cited by 1,906
- Verified
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Eggermont, A. M. M., Chiarion-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., et al. (2015) · The Lancet Oncology
Cutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers
Cited by 1,262
- Verified
Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
Ulloa-Montoya, F., Louahed, J., Dizier, B., Gruselle, O., Spiessens, B., Lehmann, F. F., Suciu, S., Kruit, W. H. J., Eggermont, A. M. M., Vansteenkiste, J., et al. (2013) · Journal of Clinical Oncology
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 436
- Verified
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762
de Voogt, H. J., Smith, P. H., Pavone-Macaluso, M., de Pauw, M., Suciu, S., & Members of the European Organization for Research on Treatment of Cancer Urological Group (1986) · Journal of Urology
Prostate Cancer Treatment and ResearchChemotherapy-induced cardiotoxicity and mitigation
Cited by 186
- Verified
Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial.
Eggermont, A. M. M., Kicinski, M., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A. M., Lichinitser, M., Khattak, M., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free